CDKN2A exon 1B deletion predisposing to melanoma and neural system tumour syndrome.

Clin Exp Dermatol

Department of Dermatology, University of California, Davis, Sacramento, CA, USA.

Published: December 2022

CDKN2A at chromosome positon 9p21 is a tumour suppressor gene encoding the cell cycle regulators p16 and p14ARF. While melanoma is associated with variants affecting both transcripts, families with mutations involving the p14ARF-specific exon 1B may be predisposed to central nervous system tumours. We describe a family with a deletion of exon 1B in CDKN2A, who had multiple cutaneous melanomas, neural tumours and various malignancies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712160PMC
http://dx.doi.org/10.1111/ced.15354DOI Listing

Publication Analysis

Top Keywords

cdkn2a exon
4
exon deletion
4
deletion predisposing
4
predisposing melanoma
4
melanoma neural
4
neural system
4
system tumour
4
tumour syndrome
4
syndrome cdkn2a
4
cdkn2a chromosome
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!